AmniSure

Germantown, United States Founded: 2005 • Age: 21 yrs Acquired By Qiagen
Diagnostic immunoassay for detection of Rupture of Membranes in pregnant women
Request Access

About AmniSure

AmniSure is a company based in Germantown (United States) founded in 2005 was acquired by Qiagen in May 2012.. AmniSure operates in a competitive market with competitors including Natera, BillionToOne, SYNLAB, Progenity and Auxogyn, among others.

  • Headquarter Germantown, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Qiagen

    (May 03, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of AmniSure

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AmniSure

AmniSure has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Qiagen. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Products and reagents for molecular diagnostic assays are supplied.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AmniSure

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AmniSure

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Amnisure Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AmniSure

AmniSure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natera, BillionToOne, SYNLAB, Progenity and Auxogyn, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Provider of cell-free cancer liquid biopsy test
domain founded_year HQ Location
Provider of medical diagnosis and clinical laboratory analysis services
domain founded_year HQ Location
Non-invasive prenatal genomic testing is provided for genetic disorders.
domain founded_year HQ Location
Diagnostic technologies for IVF embryo viability assessment are developed.
domain founded_year HQ Location
Sensitive multiplex platforms for QPCR are developed using toehold probes.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Amnisure

Frequently Asked Questions about AmniSure

When was AmniSure founded?

AmniSure was founded in 2005.

Where is AmniSure located?

AmniSure is headquartered in Germantown, United States.

Who is the current CEO of AmniSure?

Michael Friedman is the current CEO of AmniSure.

What does AmniSure do?

AmniSure was founded in 2005 in Germantown, United States, and operates in the medical diagnostics sector focused on obstetrics. A proprietary test, the AmniSure ROM Test, is developed and marketed to identify premature rupture of fetal membranes through detection of the PAMG-1 protein marker in amniotic fluid. This addresses a condition affecting about 10 of pregnancies and 30 of preterm cases.

Who are the top competitors of AmniSure?

AmniSure's top competitors include Natera, BillionToOne and Overture Life.

Who are AmniSure's investors?

AmniSure has 1 investor. Key investors include Qiagen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available